查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1361745

全球口服固體製劑合約製造市場報告

Global Oral Solid Dosage Contract Manufacturing Market Report
出版日期: | 出版商: Value Market Research | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2030 年，全球口服固體製劑合約製造市場的市場規模將從 2022 年的 329.7 億美元達到近 615.7 億美元，2023-2030 年研究期間年複合成長率為 8.12%。

推動口服固體製劑合約製造市場的主要因素包括病毒和慢性疾病的流行以及可治癒疾病的藥品的增加。此外，藥物的廣泛使用等其他因素導致了對大規模生產創新療法來治療各種疾病的患者的廣泛需求。隨著大規模生產需求的增加，大型製藥公司逐漸外包合約製造。因此，隨著對創新藥物的需求增加，對口服固體劑合約生產的需求也將增加。未來幾年，經濟繁榮和健康意識的提高預計也將對市場成長產生正面影響。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球口服固體製劑合約製造市場的每個細分市場進行了包容性評估。口服固體製劑合約製造業的成長和趨勢為本研究提供了整體方法。

區域分析：

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲口服固體製劑合約製造市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。口服固體製劑合約製造市場的主要參與者包括 Catalent Inc、Lonza Group、Piramal Pharma Solutions、Aenova、Jubilant、Boehringer Ingelheim、AbbVie Contract Manufacturing、Patheon、Recipharm、Next Pharma AB、Siegfried AG、Corden Pharma。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

目錄

第 1 章：前言

  • 報告說明
    • 客觀的
    • 目標受眾
    • 獨特的銷售主張 (USP) 和產品
  • 研究範圍
  • 研究方法論
    • 市場研究過程
    • 市場研究方法論

第 2 章：執行摘要

  • 市場亮點
  • 全球市場概況

第 3 章：口服固體製劑合約製造 - 產業分析

  • 簡介 - 市場動態
  • 市場促進因素
  • 市場限制
  • 機會
  • 產業動態
  • 波特五力分析
  • 市場吸引力分析
    • 市場吸引力分析：按產品類型
    • 市場吸引力機制分析
    • 最終用戶的市場吸引力分析
    • 市場吸引力分析：按地區

第 4 章：價值鏈分析

  • 價值鏈分析
  • 原料分析
    • 原料清單
    • 原料廠商清單
    • 主要原物料價格走勢
  • 潛在買家名單
  • 行銷管道
    • 直效行銷
    • 間接行銷
    • 行銷通路發展趨勢

第 5 章：COVID-19 爆發的影響分析

第 6 章：全球口服固體製劑合約製造市場分析：依產品類型

  • 概述：按產品類型
  • 歷史和預測數據
  • 分析：依產品類型
  • 平板電腦
  • 膠囊
  • 粉末
  • 顆粒劑
  • 其他（含片、軟糖、錠劑等）

第 7 章：全球口服固體製劑合約製造市場分析：按機制

  • 按機制概述
  • 歷史和預測數據
  • 按機制分析
  • 立即發布
  • 延遲發布
  • 控釋

第 8 章：全球口服固體製劑合約製造市場銷售分析：按最終用戶分類

  • 最終用戶概述
  • 歷史和預測數據
  • 最終用戶分析
  • 大型公司
  • 中小型企業
  • 其他（新創公司和學名藥公司）

第 9 章：全球口服固體製劑合約製造市場銷售分析：按地理位置

  • 區域展望銷售分析
  • 簡介 銷售分析
  • 北美銷售分析
    • 概述、歷史和預測銷售分析
    • 北美按細分市場銷售分析
    • 北美按國家銷售分析
    • 美國銷售分析
    • 加拿大銷售分析
    • 墨西哥銷售分析
  • 歐洲銷售分析
    • 概述、歷史和預測銷售分析
    • 歐洲按細分市場銷售分析
    • 歐洲按國家銷售分析
    • 英國銷售分析
    • 法國銷售分析
    • 德國銷售分析
    • 義大利銷售分析
    • 俄羅斯銷售分析
    • 歐洲其他地區銷售分析
  • 亞太地區銷售分析
    • 概述、歷史和預測銷售分析
    • 亞太地區按細分市場銷售分析
    • 亞太地區國家/地區銷售分析
    • 中國銷售分析
    • 印度銷售分析
    • 日本銷售分析
    • 韓國銷售分析
    • 澳洲銷售分析
    • 亞太地區其他地區銷售分析
  • 拉丁美洲銷售分析
    • 概述、歷史和預測銷售分析
    • 拉丁美洲按細分市場銷售分析
    • 拉丁美洲按國家銷售分析
    • 巴西銷售分析
    • 阿根廷銷售分析
    • 秘魯銷售分析
    • 智利銷售分析
    • 拉丁美洲其他地區銷售分析
  • 中東和非洲銷售分析
    • 概述、歷史和預測銷售分析
    • 中東和非洲按細分市場銷售分析
    • 中東和非洲國家銷售分析
    • 沙烏地阿拉伯銷售分析
    • 阿拉伯聯合大公國銷售分析
    • 以色列銷售分析
    • 南非銷售分析
    • 中東其他地區和非洲銷售分析

第 10 章：口服固體製劑合約製造公司的競爭格局

  • 口服固體製劑合約製造市場競爭
  • 夥伴關係/協作/協議
  • 併購
  • 新產品發布
  • 其他發展

第 11 章：公司簡介

  • 十大公司股票分析
  • 市場集中度
  • Catalent Inc
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Lonza Group
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Piramal Pharma Solutions
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Aenova
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Jubilant
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Boehringer Ingelheim
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • AbbVie Contract Manufacturing
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Patheon
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Recipharm
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Next Pharma AB
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Siegfried AG
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展
  • Corden Pharma
    • 公司簡介
    • 公司收入
    • 產品
    • 最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

Product Code: VMR11218732

The global demand for Oral Solid Dosage Contract Manufacturing Market is presumed to reach the market size of nearly USD 61.57 BN by 2030 from USD 32.97 BN in 2022 with a CAGR of 8.12% under the study period 2023 - 2030.

The major factors driving the oral solid dosage contract manufacturing market include the prevalence of viral and chronic diseases and increased pharmaceutical goods that can cure diseases. Moreover, additional factors like the widespread usage of pharmaceutical drugs have caused the extensive need for the large-scale production of innovative treatments for patients suffering from various ailments. Major pharmaceutical corporations are progressively outsourcing contract manufacturing as the need for large-scale production increases. As a result, as demand for innovative medicines rises, so will the need for oral solid dose contract manufacturing. In the years to come, higher economic prosperity and greater health awareness are also projected to positively impact market growth.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of oral solid dosage contract manufacturing. The growth and trends of oral solid dosage contract manufacturing industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the oral solid dosage contract manufacturing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

  • Tablets
  • Capsules
  • Powders
  • Granules
  • Others (Lozenges, Gummies, Pastilles, Etc.)

By Mechanism

  • Immediate-Release
  • Delayed-Release
  • Controlled-Release

By End-User

  • Large-Size Companies
  • Medium- & Small-Size Companies
  • Others (Startups & Generic Pharmaceutical Companies)

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Oral Solid Dosage Contract Manufacturing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the oral solid dosage contract manufacturing market include Catalent Inc, Lonza Group, Piramal Pharma Solutions, Aenova, Jubilant, Boehringer Ingelheim, AbbVie Contract Manufacturing, Patheon, Recipharm, Next Pharma AB, Siegfried AG, Corden Pharma. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . ORAL SOLID DOSAGE CONTRACT MANUFACTURING - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product Type
    • 3.7.2 Market Attractiveness Analysis By Mechanism
    • 3.7.3 Market Attractiveness Analysis By End-user
    • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET ANALYSIS BY PRODUCT TYPE

  • 6.1 Overview by Product Type
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Product Type
  • 6.4 Tablets Historic and Forecast Sales by Regions
  • 6.5 Capsules Historic and Forecast Sales by Regions
  • 6.6 Powders Historic and Forecast Sales by Regions
  • 6.7 Granules Historic and Forecast Sales by Regions
  • 6.8 Others (Lozenges, Gummies, Pastilles, etc.) Historic and Forecast Sales by Regions

7 . GLOBAL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET ANALYSIS BY MECHANISM

  • 7.1 Overview by Mechanism
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Mechanism
  • 7.4 Immediate-release Historic and Forecast Sales by Regions
  • 7.5 Delayed-release Historic and Forecast Sales by Regions
  • 7.6 Controlled-release Historic and Forecast Sales by Regions

8 . GLOBAL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SALES ANALYSIS BY END-USER

  • 8.1 Overview by End-user
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by End-user
  • 8.4 Large-size Companies Historic and Forecast Sales by Regions
  • 8.5 Medium- & Small-size Companies Historic and Forecast Sales by Regions
  • 8.6 Others (Startups & Generic Pharmaceutical Companies) Historic and Forecast Sales by Regions

9 . GLOBAL ORAL SOLID DOSAGE CONTRACT MANUFACTURING MARKET SALES ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook Sales Analysis
  • 9.2. Introduction Sales Analysis
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE ORAL SOLID DOSAGE CONTRACT MANUFACTURING COMPANIES

  • 10.1. Oral Solid Dosage Contract Manufacturing Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF ORAL SOLID DOSAGE CONTRACT MANUFACTURING INDUSTRY

  • 11.1. Top 10 Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Catalent Inc
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. Lonza Group
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Piramal Pharma Solutions
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Aenova
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. Jubilant
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Boehringer Ingelheim
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. AbbVie Contract Manufacturing
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Patheon
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Recipharm
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Next Pharma AB
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Siegfried AG
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Corden Pharma
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Product Type (USD MN)
  • Tablets Market Sales by Geography (USD MN)
  • Capsules Market Sales by Geography (USD MN)
  • Powders Market Sales by Geography (USD MN)
  • Granules Market Sales by Geography (USD MN)
  • Others (Lozenges, Gummies, Pastilles, etc.) Market Sales by Geography (USD MN)
  • Analysis Market by Mechanism (USD MN)
  • Immediate-release Market Sales by Geography (USD MN)
  • Delayed-release Market Sales by Geography (USD MN)
  • Controlled-release Market Sales by Geography (USD MN)
  • Analysis by End-user (USD MN)
  • Large-size Companies Market Sales by Geography (USD MN)
  • Medium- & Small-size Companies Market Sales by Geography (USD MN)
  • Others (Startups & Generic Pharmaceutical Companies) Market Sales by Geography (USD MN)
  • Global Oral Solid Dosage Contract Manufacturing Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Oral Solid Dosage Contract Manufacturing Report
  • Market Research Process
  • Market Research Methodology
  • Global Oral Solid Dosage Contract Manufacturing Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Product Type
  • Market Attractiveness Analysis by Mechanism
  • Market Attractiveness Analysis by End-user
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Product Type (USD MN)
  • Tablets Market Sales by Geography (USD MN)
  • Capsules Market Sales by Geography (USD MN)
  • Powders Market Sales by Geography (USD MN)
  • Granules Market Sales by Geography (USD MN)
  • Others (Lozenges, Gummies, Pastilles, etc.) Market Sales by Geography (USD MN)
  • Global Market Analysis by Mechanism (USD MN)
  • Immediate-release Market Sales by Geography (USD MN)
  • Delayed-release Market Sales by Geography (USD MN)
  • Controlled-release Market Sales by Geography (USD MN)
  • Global Market Analysis by End-user (USD MN)
  • Large-size Companies Market Sales by Geography (USD MN)
  • Medium- & Small-size Companies Market Sales by Geography (USD MN)
  • Others (Startups & Generic Pharmaceutical Companies) Market Sales by Geography (USD MN)
  • Global Market by Revenue
  • North America Market by Revenue
  • Europe Market by Revenue
  • Asia Pacific Market by Revenue
  • Latin America Market by Revenue
  • Middle East & Africa Market by Revenue
  • Recent Development in Industry
  • Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.